FDS:NYSEFactSet Research Systems Inc. Analysis
Data as of 2026-04-02 - not real-time
$227.68
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
FactSet is trading below its 200‑day SMA, indicating a short‑term bearish bias, yet the RSI in the low‑60s shows momentum remains on the upside side. The MACD histogram is positive and the signal line turned bullish, suggesting a possible technical rebound. Valuation metrics are attractive: the current price sits well under the DCF‑derived fair value and the PE of ~14.5x is below the industry average of ~16.6x. Revenue is growing at roughly 7% YoY with robust gross and operating margins, and the company generates solid free cash flow to support its 27% payout ratio. Dividend yield near 2% adds income appeal, while the balance sheet shows manageable leverage with a debt‑to‑equity around 73% and ample cash. However, the stock has experienced a 30‑day volatility of over 40% and a historic max drawdown near 60%, underscoring heightened price swings.
Given the upside potential of roughly 11% versus the fair‑value estimate, the blend of growth and value characteristics makes FactSet a compelling buy for investors with a medium to long horizon. The increasing volume trend supports the technical case for a bounce, while the low beta (≈0.6) tempers market‑wide risk. Dividend sustainability appears sound, and the company’s global client base reduces geographic concentration risk. Overall, the fundamentals, dividend profile, and valuation suggest a favorable outlook despite near‑term price pressure.
Given the upside potential of roughly 11% versus the fair‑value estimate, the blend of growth and value characteristics makes FactSet a compelling buy for investors with a medium to long horizon. The increasing volume trend supports the technical case for a bounce, while the low beta (≈0.6) tempers market‑wide risk. Dividend sustainability appears sound, and the company’s global client base reduces geographic concentration risk. Overall, the fundamentals, dividend profile, and valuation suggest a favorable outlook despite near‑term price pressure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below short‑term moving averages
- Positive MACD histogram indicating potential bounce
- High short‑term volatility and bearish SMA alignment
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests ~11% upside
- Strong cash flow and sustainable dividend
- Revenue growth with solid margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust ROE and consistent profitability
- Diversified global client base reducing concentration risk
- Undervalued relative to peers with attractive dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth7.10%
Profit Margin24.48%
P/E Ratio14.5
ROE28.08%
ROA11.06%
Debt/Equity72.97
P/B Ratio3.9
Op. Cash Flow$798.9M
Free Cash Flow$596.3M
Industry P/E16.6
Technical Analysis
TrendBearish
RSI62.3
Support$191.23
Resistance$231.21
MA 20$209.23
MA 50$218.39
MA 200$305.08
MACDBullish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair Value$256.79
Target Price$252.69
Upside/Downside10.98%
GradeUndervalued
TypeBlend
Dividend Yield1.96%
Risk Assessment
Beta0.62
Volatility40.94%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.